Lunch Program: Optimizing Antiplatelet Therapy in Cardiogenic Shock

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The Society for Cardiovascular Angiography and Interventions designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Participants can earn ABIM MOC points equivalent to the amount of CME credits claimed for the activity.

Acknowledgment of Commercial Support
This activity is supported by an unrestricted educational grant from Chiesi. No in-kind commercial support was received.

Welcoming Remarks

Jennifer A Rymer, MD, MBA, MHS, Duke University Hospital, Chapel Hill, NC

Download Slides

Case Presentation, Part 1

Anezi Uzendu, The University of Texas Southwestern Medical Center

View Recording Download Slides

The Pharmacodynamics of Antiplatelet and Antithrombotic Therapies in Cardiogenic Shock: How to Mitigate Ischemia and Bleeding

Timothy D. Henry, M.D., MSCAI, The Christ Hospital Health Network, Covington, KY

View Recording Download Slides

Discussion

Jennifer A Rymer, MD, MBA, MHS, Duke University Hospital, Chapel Hill, NC

Download Slides

The Use of Cangrelor in ACS and Cardiogenic Shock: Lessons Learned from Trial and Registry Data

Jennifer A Rymer, MD, MBA, MHS, Duke University Hospital, Chapel Hill, NC

View Recording Download Slides

Discussion

Jennifer A Rymer, MD, MBA, MHS, Duke University Hospital, Chapel Hill, NC

Download Slides

Optimal Antiplatelet and Antithrombotic Strategies in High-Risk ACS and Special Patient Populations: Not Your Textbook Patients

Greg W Serrao, MD, FSCAI, Icahn School of Medicine at Mount Sinai, New York, NY

2023 SCAI SHOCK

Lunch Program: Optimizing Antiplatelet Therapy in Cardiogenic Shock